VRMED: The first VR solution in MedTech
The VR helmet is capable of replacing 40% of all instrument functionality ophthalmology room
International Business Development, Bionesty Ltd., Representative of VR MED in EU, UK
Founder and general director of Bionesty ltd., London. Has extensive experience in medicine, clinical trials and promotion of startups in the field of medical technology. In the team, represents the VR MED's interests in the European Union and Great Britain.
- crowd sale (20000000)
- team, bounty, marketing (4000000)
- ICO 2.0 reserve (6000000)
- Headset refinement (including functional expansion) ($1000000)
- IT costs (SW, DB developers), headset technical developers (improvement of the eye-tracker, eeg) ($1000000)
- Project marketing (opinion leaders, conferences, publications in specialized media) ($900000)
- Certification in the countries of EurAsEC, EU, India, China ($2100000)
Cost of the token1 token for 0.25 $
Price without discounts
Rate the project
Estimate the project on a five-point scale or switch to the simple scale
Estimate the project on a simple scale or switch to the five-point scale
Relevance of the problem and Market size
Founders, Team & Advisors
Budget allocation and roadmap
Token economy, Tokenization & Business model
Distribution & Lock up of tokens, Discounts for early buyers
Summary rate the project
Rate the project by other users1
It is very interesting project. The project use virtual reality in the field of health. A new solution allows you to save a large amount of money and can replace the equipment of the entire ophthalmologic cabinet.
Risks and disadvantages
I can’t count no obvious minuses of this project, the project has no competition, and besides, the healthcare field is fundamentally different from the games industry, where the virtual reality is mostly used. This project will help to solve many problems in the ophthalmology field, replacing many expensive equipment.
This is without a doubt a very promising project that will become successful very soon. If you invest in it, you would get good profits even in the short term and will also give impetus to the integration of distributed technologies in the health sector.